Pharmaceutical Dissolution Testing measures the release of a drug product’s active substance in a controlled laboratory environment that mimics in-vivo conditions. This test is a key parameter in evaluating drug development and manufacturing. It is the only standardized way to generate scientific data that enables predicting bioavailability (a surrogate parameter of therapeutic efficacy), indicating the robustness of the dosage form (drug product safety), and implicating variations in manufacturing (which may have a critical influence on performance).
- Home
- Pharmaceutical Development
- Biologics R&D
- Laboratory Testing
- Quality Compliance Consulting
- Validation Studies
- FDA Pre-Approval Readiness
- Regulatory Filing Services
- Six Sigma Projects
- FDA Inspection Remediation
- Supplier Audits
- Post market surveillance & MDR
- Quality system gap assessment
- Medical Devices Quality System
- cGMP Auditing & Training
- Quality System Development
- Equipment Qualification (IQ/OQ/PQ)
- CAPA Investigations